Flow Diverters Market
Report ID: SQMIG35A3793
Report ID: SQMIG35A3793
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3793 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
121
|Figures:
77
Global Flow Diverters Market size was valued at USD 454.59 Million in 2024 and is poised to grow from USD 504.55 Million in 2025 to USD 1161.92 Million by 2033, growing at a CAGR of 10.99% during the forecast period (2026-2033).
Flow diverters are implantable braided stents used to treat intracranial aneurysms by redirecting blood flow away from the aneurysm sac, and the market encompasses device manufacturers, hospitals, and regulatory agencies. The primary driver of market expansion is increasing diagnosis of complex aneurysms with expanding clinical evidence that flow diversion yields higher long-term occlusion rates than coil embolization for wide-necked aneurysms. Originally introduced a decade ago for large proximal aneurysms, technology evolved to smaller profile devices suitable for distal vessels, enabling broader adoption in neurointervention suites. As procedural expertise and reimbursement pathways improved, demand shifted from niche applications to routine use.
As clinicians gained experience and devices became smaller and more deliverable, hospitals expanded endovascular programs, driving market growth and creating opportunities for manufacturers to develop next-generation flow diverters for distal anatomy. This evolution produced use cases that reinforced adoption; for example patients with previously untreatable wide-neck or fusiform aneurysms achieved durable occlusion and required fewer retreatments than with coils. Improved designs lowered complications and therefore prompted payer coverage in multiple regions which enabled broader procurement by health systems. Growing aneurysm incidence among aging populations in Asia combined with expanded training initiatives now presents clear commercial openings for targeted expansion worldwide.
How is Ai Driving Adoption in the Flow Diverters Market?
Through automating images via AI, flow diversions can now be more easily chosen for patients due to better patient selection, procedural planning; as well as device sizing. Machine Learning models predicting thrombo-embolic risks, in silico hemodynamic simulations that can provide data to size and deploy flow diversions, and advanced image segmentation that reduces the amount of time required to complete a plan. The marketplace itself is moving in the direction of platform-driven workflows which will allow neurointerventionalists utilizing an AI based plan and predicting optimal outcomes to feel more confident about flow diversion. Real world studies and systematic reviews show growing use of AI guided simulation and prediction to support complex case decisions.
Mentice and Siemens Healthineers June 2026, announced a co marketing agreement to connect imaging hardware with virtual planning software that enables patient specific simulation and treatment rehearsal. This AI enabled integration streamlines device selection and operator training and supports faster, more confident adoption of flow diverters.
Market snapshot - (2026-2033)
Global Market Size
USD 454.59 Million
Largest Segment
Pipeline Embolization Device
Fastest Growth
Surface-Modified Flow Diverters
Growth Rate
10.99% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global flow diverters market is segmented by product type, material, application, end-user and region. Based on product type, the market is segmented into pipeline embolization device, surface-modified flow diverters, braided mesh designs and others. Based on material, the market is segmented into cobalt-chromium, nitinol-platinum, cobalt chromium-platinum and others. Based on application, the market is segmented into intracranial aneurysm, aortic aneurysm, vascular aneurysm and others. Based on end-user, the market is segmented into hospitals and ambulatory surgical centers, neuro-interventional centers, specialty clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on the global flow diverters market growth, pipeline embolization device segment dominates because these devices have become the clinical standard for wide-neck and complex intracranial aneurysms, driving preference among neurointerventionalists for proven efficacy and predictable vessel remodeling. Their established clinical track record and physician familiarity create high adoption, incentivize investment by manufacturers, and influence hospital procurement. This cause and effect relationship helps make sure the product is market leading because of the way the consumer's demand and their day-to-day usage will both support the consumer's use of the product over another alternative that has less proven track record.
However, surface-modified flow diverters are emerging as the most rapidly expanding area due to material and coating innovations that improve endothelialization and safety profiles, attracting clinicians seeking reduced complication risks. Increasing regulations and continued improvements to devices have generated additional opportunities to increase market presence and be utilized in different ways than originally intended.
Intracranial aneurysm segment dominates because most clinical research, device design priorities, and procedural pathways in the flow diverters market are centered on treating these lesions, driving focused investment and educational efforts. The combination of high clinical need and evidence generation creates a virtuous circle, which drives product development through refinement of products and adaptation of guidelines for use in an increasing manner throughout the process of producing drugs for treating intracranial disorders. As a result, intracranial indications are the primary revenue and development drivers, respectively, for all manufacturers and service providers.
On the other hand, aortic aneurysm is witnessing the strongest growth momentum as device adaptations and clinical trials expand flow diverter applicability to larger vessel anatomies, attracting interest from vascular specialists. Adopting new techniques in technology and cross collaboration of specialty fields increases the number of available markets for growth by creating new long-term opportunities other than just intracranial applications.
To get detailed segments analysis, Request a Free Sample Report
As per the global flow diverters makrket share, North America leads due to a convergence of advanced clinical infrastructure, strong industry presence, and a favorable innovation ecosystem that supports novel neurointerventional therapies. In the regional healthcare sector, the growth of the new healthcare technology sector is bolstered by the presence of specialized expert centers that include available trained Neurointerventionalists. There are strong collaborative relationships between device manufacturers and leading clinical research organizations facilitate current devices to be clinically assessed expeditiously and establish feedback loops to improve devices through continuous iteration. Reimbursement structures and capital availability support the growth of high complexity procedures, conversely, regulatory processes along with active clinical research create development paths to create sustainable market leadership.
Flow Diverters Market in the United States benefits from a dense network of tertiary hospitals and specialist referral centers that concentrate procedural expertise and drive technology adoption. Clinical research hubs and active collaboration between device makers and clinicians accelerate innovation and real world learning. Payer systems and facilities are supporting the introduction of advanced devices through financial means, whereas a very dynamic and competitive medtech environment is producing an ongoing cycle of refinement in both device design and procedural methods to maintain leadership in both device adoption as well as clinical use.
Flow Diverters Market in Canada reflects a mature public healthcare environment where adoption is shaped by regional procurement and centralized specialty centers. Large metropolitan health facilities specialize in clinical expertise while developing standardized care pathways and providing additional specialist training opportunities. Many reimbursement and funding decisions are influenced by health technology assessment and collaboration between provinces; this has a direct impact on the speed of implementation for new technologies. Academic health facilities and collaborative networks have developed mechanisms to support clinical evaluation and to exchange knowledge.
Europe is experiencing rapid expansion driven by a combination of growing clinical acceptance, coherent regulatory frameworks, and active engagement from both global and regional medtech companies. Due to improved availability of neurovascular centers, an increase in specialty providers being trained has resulted in a much higher number of procedures done throughout the United States as well as an increase in the confidence level of the clinicians providing these treatments. Having a well defined process for assessing and reimbursing neurovascular treatments allows health systems to be more interested in expanding into different market areas than in the past. Collaborative efforts between countries working together, centralizing purchases together as well as creating and following clinical guidelines, and allows for more consistent practices from clinicians.
Flow Diverters Market in Germany is characterized by a robust hospital infrastructure and a strong tradition of medical technology adoption. High volumes of highly specialized medical procedures in specialty centers allow for speedy clinical iterations and evidence generation when coupled with the close collaboration between clinician and device developer. Current reimbursement systems and hospital funding mechanisms provide access to cutting-edge neurointervention devices; and the robust medtech ecosystem produces a supply chain with the ability to continue to innovate and maintain resilience.
Flow diverters market in the United Kingdom is marked by dynamic adoption driven by coordinated specialist networks and focused investment in tertiary neurovascular services. Emphasis on clinical governance and outcome measurement supports selective deployment in centers of excellence, while national guidance and procurement frameworks influence uptake. Participating in clinical trials and being trained on new devices increases physician skills and confidence; the collaboration between hospitals and manufacturers helps expedite the introduction of future devices. The combination of strategic investment and centralized expertise underpins rapid market growth.
Flow diverters market in France is emerging through consolidation of specialist centers and strengthening of clinical pathways for neurointerventional care. Investment in training and multidisciplinary collaboration is increasing procedural capacity and readiness to adopt new technologies. There is an increasing amount of engagement between clinicians and manufacturers as reimbursement processes and regional hospital planning adapt to accommodate these more advanced devices. Therefore, while the use of flow diverters will gradually grow with the aggregate clinical experience and evidence that develop over time.
As per global flow diverters regional outlook, Asia Pacific is strengthening its role through targeted healthcare investments, regulatory modernization, and growing clinical expertise in neurointervention. Regions are boosting procedural capability through increased presence in the region of specialized centers and increased training initiatives resulting in an increase in the number of skilled personnel. Increased cooperation between global manufacturers and local partners is facilitating the introduction of customized products and supply chain development. The policy focus on increasing access to advanced care and gradually expanding reimbursement will provide favorable conditions for wider adoption. Collectively, these will result in moving the region from being an adopter to becoming an innovator in particular markets, thus expanding clinical applications and availability of devices.
Flow diverters market in Japan is shaped by a sophisticated regulatory and clinical ecosystem that emphasizes safety and evidence generation. With an abundance of clinical experience at many tertiary hospitals, along with a robust domestic medtech industry, there is ample opportunity for thoughtful adoption and refinement of devices through both refined processes and cross-functional collaboration by working through complex clinical protocols. The combination of clinical rigor and industry engagement positions Japan as a key advanced market within the region.
Flow diverters market in South Korea is characterized by rapid clinical uptake supported by well developed hospital systems and active collaboration between clinicians and manufacturers. Maintaining proficiency as an operator through focused training initiatives or centers of excellence can be a means to increase the availability of procedures. Evolving reimbursement trends and hospital investment patterns can contribute to ongoing development of advanced services for neurointervention throughout the continuum of care.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Incidence Of Aneurysms
Advances In Device Design
High Procedural Complexity And Training
Reimbursement And Cost Challenges
Request Free Customization of this report to help us to meet your business objectives.
Market competition in the global flow diverters market outlook is intensifying as strategics use acquisitions to broaden portfolios while incumbents push material and delivery innovations to differentiate flow diverters; recent examples include large medtech M&A and surface coating launches that specifically target thrombogenicity and deliverability improvements. Strategic moves now combine targeted acquisitions, regulatory filings, and co development partnerships to secure clinical channels and speed adoption.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global flow diverters industry is poised for sustained expansion driven primarily by rising diagnosis of complex intracranial aneurysms, supported by advances in device design that improve deliverability and outcomes. The Pipeline Embolization Device segment remains dominant due to its established clinical track record for wide-neck and complex aneurysms, while North America leads the market owing to advanced clinical infrastructure, strong industry presence and supportive reimbursement pathways. A notable restraint continues to be high procedural complexity and the steep training curve required for safe, consistent implantation, which limits adoption outside specialized centers. Continued innovation and AI-enabled planning are expected to broaden use and shorten the learning curve.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 454.59 Million |
| Market size value in 2033 | USD 1161.92 Million |
| Growth Rate | 10.99% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Flow Diverters Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Flow Diverters Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Flow Diverters Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Flow Diverters Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Flow Diverters Market size was valued at USD 454.59 Million in 2024 and is poised to grow from USD 504.55 Million in 2025 to USD 1161.92 Million by 2033, growing at a CAGR of 10.99% during the forecast period (2026-2033).
Market competition is intensifying as strategics use acquisitions to broaden portfolios while incumbents push material and delivery innovations to differentiate flow diverters; recent examples include large medtech M&A and surface coating launches that specifically target thrombogenicity and deliverability improvements. Strategic moves now combine targeted acquisitions, regulatory filings, and co development partnerships to secure clinical channels and speed adoption. 'Medtronic', 'Stryker', 'MicroPort Scientific', 'Johnson & Johnson', 'Terumo Corporation', 'Penumbra', 'Balt', 'MicroVention', 'Phenox', 'InspireMD', 'Wallaby Medical', 'Perflow Medical', 'Rapid Medical', 'Acandis', 'Cerus Endovascular', 'Evasc', 'Sensome', 'Silk Road Medical', 'Vasorum', 'Vascular Dynamics'
Increasing clinical prevalence of intracranial aneurysms has expanded the pool of patients eligible for endovascular therapy, creating greater demand for flow diverter devices. As clinicians seek durable, minimally invasive options that can redirect blood flow and promote aneurysm occlusion, hospitals and specialists are more likely to adopt these implants. Growing familiarity among neurointerventionalists with device handling and post-procedure management further supports procedure uptake, while perceived benefits in patient outcomes encourage referral patterns and investment in training and infrastructure to support broader clinical use.
Broadening Clinical Indications: Growing clinical experience and device refinements are expanding consideration of flow diverters across wider spectrum of cerebrovascular pathologies. Physicians increasingly evaluate these devices for distal anatomies, complex morphologies, recurrent lesions, and as components of therapeutic strategies with adjunctive measures. This evolution is reinforced by accumulating real world evidence, collaborative multidisciplinary care models, and updated practice patterns that prioritize personalized risk assessment and long term vessel reconstruction, enabling more tailored treatment pathways and improved patient selection for less invasive vascular repair.
Why does North America Dominate the Global Flow Diverters Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
